Immunology, Microbiology & Inflammatory Bowel Diseases

Members interested in participating in the activities of the AGA Institute Council Immunology, Microbiology & Inflammatory Bowel Diseases Section should contact us at . We are especially interested in increasing participation of junior investigators, clinicians and international members.



The IMIBD section executes the AGA's strategic plan by providing an international forum to present and evaluate the most exciting and innovative research in the field. By providing a forum for debate, collaboration and an exchange of ideas, the IMIBD section helps define what is state-of-the-art care in IBD and pushes the boundaries of science in search of a cure.  Established and emerging leaders collate this information to provide education and training to both the next generation of researchers as well as for providers caring for patients with IBD. This enhanced knowledge leads to improved practice and quality, ultimately showing the value of section through the work of its diverse members.

Areas of Focus:

  • Clinical research in IBD.
  • Clinical management related to IBD.
  • Basic and translational research related to IBD.
  • Research topics include but are not limited to:
    • Immunology.
    • Microbiome.
    • Epidemiology.
    • Novel therapy (mouse models and human).
    • Optimizing existing therapy.
    • Disease and therapy related adverse events.
    • Diagnostics and imaging.
    • Epidemiology.
    • Diet and environment.

Council Leadership

Mark S. Silverberg, MD, PhD 
Mount Sinai Hospital


Uma Mahadevan, MD, AGAF 
UCSF Center for Colitis and Crohn's Disease 
Vice Chair